ATE334146T1 - METHOD FOR PRODUCING ERYTHROPOIETIN FREE OF ANIMAL PROTEINS - Google Patents
METHOD FOR PRODUCING ERYTHROPOIETIN FREE OF ANIMAL PROTEINSInfo
- Publication number
- ATE334146T1 ATE334146T1 AT03016548T AT03016548T ATE334146T1 AT E334146 T1 ATE334146 T1 AT E334146T1 AT 03016548 T AT03016548 T AT 03016548T AT 03016548 T AT03016548 T AT 03016548T AT E334146 T1 ATE334146 T1 AT E334146T1
- Authority
- AT
- Austria
- Prior art keywords
- host cell
- animal proteins
- producing erythropoietin
- protein
- free
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000003951 Erythropoietin Human genes 0.000 title abstract 2
- 108090000394 Erythropoietin Proteins 0.000 title abstract 2
- 229940105423 erythropoietin Drugs 0.000 title abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
New therapeutic compsn. contains a protein (I) with erythropoietin activity produced in a host cell and: (a) contg. \~ 100 ppm protein from the host cell; (b) contg. \~ 10 pg DNA from the host cell per 83 ~mg (I), and (c) being entirely free of natural mammalian protein not derived from the host cell.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95107165 | 1995-05-11 | ||
| DE19522461 | 1995-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE334146T1 true ATE334146T1 (en) | 2006-08-15 |
Family
ID=26016131
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96919753T ATE258189T1 (en) | 1995-05-11 | 1996-05-10 | METHOD FOR PRODUCING ERYTHROPOIETIN FREE OF ANIMAL PROTEINS |
| AT03016548T ATE334146T1 (en) | 1995-05-11 | 1996-05-10 | METHOD FOR PRODUCING ERYTHROPOIETIN FREE OF ANIMAL PROTEINS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96919753T ATE258189T1 (en) | 1995-05-11 | 1996-05-10 | METHOD FOR PRODUCING ERYTHROPOIETIN FREE OF ANIMAL PROTEINS |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6399333B1 (en) |
| EP (2) | EP1394179B1 (en) |
| JP (1) | JP3061200B2 (en) |
| AT (2) | ATE258189T1 (en) |
| AU (1) | AU5817496A (en) |
| CA (1) | CA2220515C (en) |
| DE (2) | DE59611371D1 (en) |
| DK (2) | DK0830376T3 (en) |
| ES (2) | ES2268232T3 (en) |
| IL (2) | IL118201A (en) |
| PT (2) | PT1394179E (en) |
| WO (1) | WO1996035718A1 (en) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU729459B2 (en) * | 1996-11-15 | 2001-02-01 | Genentech Inc. | Purification of neurotrophins |
| JP4541539B2 (en) * | 1997-07-23 | 2010-09-08 | ロシュ ダイアグノスティックス ゲーエムベーハー | Production of erythropoietin by endogenous gene activation |
| US6548296B1 (en) * | 1997-07-23 | 2003-04-15 | Roche Diagnostics Gmbh | Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof |
| WO1999028346A1 (en) | 1997-12-03 | 1999-06-10 | Roche Diagnostics Gmbh | Erythropoietin with high specific activity |
| NZ507557A (en) | 1998-05-06 | 2003-10-31 | Genentech Inc | Protein purification by ion exchange chromatography |
| BR9917606A (en) * | 1998-11-06 | 2002-12-31 | Bio Sidus S A | Procedure for the purification of recombinant human erythropoietin from cell culture supernatants and recombinant human erythropoietin obtained with such procedure |
| BR9905868A (en) | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Mass culture procedure for mammalian cells to obtain recombinant human erythropoietin and recombinant human erythropoietin obtained with such procedure |
| BR9905867A (en) * | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Recombinant human erythropoietin-producing cell line and the recombinant human erythropoietin produced by this cell |
| JO2291B1 (en) | 1999-07-02 | 2005-09-12 | اف . هوفمان لاروش ايه جي | Erythopintin derivatives |
| AU2002233230B2 (en) | 2000-12-20 | 2007-02-01 | F. Hoffmann-La Roche Ag | Erythropoietin conjugates |
| CN1596310A (en) * | 2001-11-28 | 2005-03-16 | 桑多斯有限公司 | Method for producing a recombinant polypeptide |
| ATE363541T1 (en) * | 2002-03-26 | 2007-06-15 | Lek Tovarna Farmacevtskih | METHOD FOR PRODUCING A DESIRED PROFILE OF ERYTHROPOIETIN GLYCO ISOFORMS |
| DE60228460D1 (en) * | 2002-12-13 | 2008-10-02 | Bioceuticals Arzneimittel Ag | Process for the preparation and purification of erythropoietin |
| US20050019914A1 (en) * | 2003-07-24 | 2005-01-27 | Aventis Pharma Deutschland Gmbh | Perfusion process for producing erythropoietin |
| EP1670821A4 (en) * | 2003-10-09 | 2006-11-29 | Daewoong Co Ltd | PROCESS FOR THE PURIFICATION OF HUMAN THROMBOPOIETIN WITH A HIGH SIALIC ACID CONTENT |
| DE102004027816A1 (en) * | 2004-06-08 | 2006-01-05 | Bioceuticals Arzneimittel Ag | Process for the purification of erythropoietin |
| US7598356B2 (en) * | 2004-07-08 | 2009-10-06 | Board of Regents of the University of Nebraska by and on behalf of the University of Nebraska Medical Center | Method for purifying a protein of the cystine-knot superfamily |
| DE602004013847D1 (en) * | 2004-11-09 | 2008-06-26 | Usv Ltd | NEW PROCESS FOR CLEANING HUMAN GROWTH HORMONE |
| ES2509872T3 (en) * | 2005-03-03 | 2014-10-20 | Allergan, Inc. | Procedures for obtaining a clostridic toxin |
| EP2495308A1 (en) | 2005-12-08 | 2012-09-05 | Amgen Inc. | Improved production of glycoproteins using manganese |
| PL2054074T3 (en) | 2006-08-04 | 2015-03-31 | Prolong Pharmaceuticals Llc | Modified erythropoietin |
| EP2089424B1 (en) * | 2006-12-06 | 2015-07-01 | JCR PHARMACEUTICALS Co., LTD. | Method for production of human erythropoietin |
| KR100988706B1 (en) | 2007-03-07 | 2010-10-18 | 한미홀딩스 주식회사 | Novel Purification Method of Recombinant Erythropoietin |
| CL2008002053A1 (en) | 2007-07-17 | 2009-05-22 | Hoffmann La Roche | Method for the purification of a monopeglated erythropoietin (epompeg) which consists of providing a solution containing mono, poly and non-peglated erythropoietin and passing it through two steps of cation exchange chromatography and a method to produce epo mpeg that includes a purification method. |
| AR067536A1 (en) * | 2007-07-17 | 2009-10-14 | Hoffmann La Roche | METHOD FOR OBTAINING A MONO-PEGILATED ERYTHROPOYETIN IN A SUBSTANTIALLY HOMOGENOUS FORM |
| KR100900033B1 (en) | 2007-11-21 | 2009-06-01 | 한국생명공학연구원 | Method for Purifying Human Erythropoietin |
| MX344166B (en) | 2008-02-08 | 2016-12-07 | Ambrx Inc | Modified leptin polypeptides and their uses. |
| DE102008002210A1 (en) * | 2008-06-04 | 2009-12-10 | Evonik Degussa Gmbh | Process for the fermentative production of erythropoietin |
| DE102008002209A1 (en) | 2008-06-04 | 2009-12-10 | Evonik Degussa Gmbh | Process for the purification of erythropoietin |
| CN102164954B (en) | 2008-09-23 | 2018-04-06 | 弗·哈夫曼-拉罗切有限公司 | The purifying of hematopoietin |
| BR122012024318A2 (en) | 2008-09-26 | 2019-07-30 | Ambrx, Inc. | MODIFIED ANIMAL ERYTHROPOETIN POLYPEPTIDES AND THEIR USES |
| DE102008054716A1 (en) | 2008-12-16 | 2010-06-17 | Evonik Degussa Gmbh | In-process control in a process for the production of EPO |
| US20120177640A1 (en) | 2009-07-24 | 2012-07-12 | Josef Burg | Optimizing the production of antibodies |
| EA022396B1 (en) | 2009-09-23 | 2015-12-30 | Ратиофарм Гмбх | Process for the purification of recombinant human erythropoietin (epo), epo thus purified and pharmaceutical compositions comprising same |
| KR101443257B1 (en) * | 2011-10-18 | 2014-09-19 | 주식회사 종근당 | Methods for Purifying Erythropoietin Analogs Having Lower Isoelectric Point |
| US10066001B2 (en) | 2013-03-15 | 2018-09-04 | Apotex Inc. | Enhanced liquid formulation stability of erythropoietin alpha through purification processing |
| WO2016116966A1 (en) * | 2015-01-22 | 2016-07-28 | Jcr Pharmaceuticals Co., Ltd. | Method for purification of recombinant human alpha-galactosidase a from material containing contaminant host cell proteins |
| DK3613486T3 (en) * | 2018-08-24 | 2021-01-04 | Uga Biopharma Gmbh | METHOD AND SYSTEM FOR CLEANING EPO AND / OR AN EPO DERIVATIVE |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| US4677195A (en) * | 1985-01-11 | 1987-06-30 | Genetics Institute, Inc. | Method for the purification of erythropoietin and erythropoietin compositions |
| IL79176A (en) * | 1985-06-20 | 1992-06-21 | Kirin Amgen Inc | Process for the recovery of erythropoietin from a fluid |
| US4954437A (en) * | 1986-09-15 | 1990-09-04 | Integrated Genetics, Inc. | Cell encoding recombinant human erythropoietin |
| AU4104889A (en) | 1988-09-07 | 1990-03-15 | Bioclones (Pty) Ltd | Purification of erythropoietin |
| DE4115722A1 (en) * | 1991-05-14 | 1992-11-19 | Boehringer Mannheim Gmbh | SERUM-FREE MEDIUM FOR CULTIVATING SUGAR CELLS |
-
1996
- 1996-05-09 IL IL11820196A patent/IL118201A/en not_active IP Right Cessation
- 1996-05-10 AT AT96919753T patent/ATE258189T1/en active
- 1996-05-10 ES ES03016548T patent/ES2268232T3/en not_active Expired - Lifetime
- 1996-05-10 ES ES96919753T patent/ES2211961T3/en not_active Expired - Lifetime
- 1996-05-10 EP EP03016548A patent/EP1394179B1/en not_active Expired - Lifetime
- 1996-05-10 US US08/945,802 patent/US6399333B1/en not_active Expired - Lifetime
- 1996-05-10 WO PCT/EP1996/001988 patent/WO1996035718A1/en not_active Ceased
- 1996-05-10 DK DK96919753T patent/DK0830376T3/en active
- 1996-05-10 EP EP96919753A patent/EP0830376B1/en not_active Expired - Lifetime
- 1996-05-10 CA CA002220515A patent/CA2220515C/en not_active Expired - Lifetime
- 1996-05-10 AT AT03016548T patent/ATE334146T1/en active
- 1996-05-10 DE DE59611371T patent/DE59611371D1/en not_active Expired - Lifetime
- 1996-05-10 PT PT03016548T patent/PT1394179E/en unknown
- 1996-05-10 AU AU58174/96A patent/AU5817496A/en not_active Abandoned
- 1996-05-10 PT PT96919753T patent/PT830376E/en unknown
- 1996-05-10 DE DE59610898T patent/DE59610898D1/en not_active Expired - Lifetime
- 1996-05-10 DK DK03016548T patent/DK1394179T3/en active
- 1996-05-10 JP JP8533775A patent/JP3061200B2/en not_active Expired - Lifetime
-
2002
- 2002-02-07 US US10/067,235 patent/US6471500B1/en not_active Expired - Lifetime
-
2003
- 2003-08-28 IL IL15764403A patent/IL157644A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL118201A0 (en) | 1996-09-12 |
| DK0830376T3 (en) | 2004-05-24 |
| PT1394179E (en) | 2006-11-30 |
| DE59610898D1 (en) | 2004-02-26 |
| WO1996035718A1 (en) | 1996-11-14 |
| JP3061200B2 (en) | 2000-07-10 |
| JPH10506924A (en) | 1998-07-07 |
| ATE258189T1 (en) | 2004-02-15 |
| PT830376E (en) | 2004-05-31 |
| CA2220515C (en) | 2003-07-22 |
| EP1394179A1 (en) | 2004-03-03 |
| EP0830376B1 (en) | 2004-01-21 |
| US6471500B1 (en) | 2002-10-29 |
| ES2211961T3 (en) | 2004-07-16 |
| AU5817496A (en) | 1996-11-29 |
| IL157644A0 (en) | 2004-03-28 |
| DK1394179T3 (en) | 2006-11-20 |
| US20020146771A1 (en) | 2002-10-10 |
| IL118201A (en) | 2004-12-15 |
| EP1394179B1 (en) | 2006-07-26 |
| CA2220515A1 (en) | 1996-11-14 |
| DE59611371D1 (en) | 2006-09-07 |
| EP0830376A1 (en) | 1998-03-25 |
| ES2268232T3 (en) | 2007-03-16 |
| US6399333B1 (en) | 2002-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE258189T1 (en) | METHOD FOR PRODUCING ERYTHROPOIETIN FREE OF ANIMAL PROTEINS | |
| ATE213271T1 (en) | METHOD FOR PRODUCING RECOMBINANT PROTEINS IN E. COLI USING HIGH CELL DENSITY FERMENTATION | |
| LU90855I2 (en) | Proteine 1 osteogenique recombinante humaine: bmp-7 et ses d-riv-s pharmaceutiquement acceptables | |
| DE68925083D1 (en) | Recombinant DNA, microorganism containing this recombinant DNA and method for producing L-amino acid using this microorganism | |
| DE3585953D1 (en) | DNA FRAGMENTS, EXPRESSION VECTORS, PROTEINS, INNOVATORS AND METHOD FOR PRODUCING THE PROTEINS. | |
| DE3667489D1 (en) | METHOD FOR PRODUCING A PROTEIN. | |
| DE3886221D1 (en) | METHOD FOR PRODUCING PROTEIN PRODUCTS IN -i (ASPERGILLUS) AND PROMOTORS FOR USE IN -i (ASPERGILLUS). | |
| DE3677399D1 (en) | METHOD FOR PRODUCING L-LYSINE. | |
| ATE179754T1 (en) | METHOD FOR PRODUCING THROMBIN | |
| DE3587422D1 (en) | DNA SEQUENCE ENCODING A HIRUDINA-LIKE PROTEIN AND METHOD FOR PRODUCING SUCH A PROTEIN. | |
| DE68909528D1 (en) | METHOD FOR PRODUCING METHACRYLIC ACID. | |
| ATE361360T1 (en) | CULTURE MEDIA FOR CULTIVATION OF ANIMAL CELLS AND METHOD FOR PRODUCING PROTEINS BY USING SAME | |
| DE3576361D1 (en) | RECOMBINANT DNA, TRANSFORMED MICROORGANISM, AND METHOD FOR PRODUCING HUMAN CU-ZN SUPEROXIDE DISISMUTASE USING THE TRANSFORMED MICROORGANISM. | |
| DE69430975D1 (en) | Process for the production of proteins | |
| DE3789833D1 (en) | Isolated phenylalanine dehydrogenase gene and method for producing phenylalanine dehydrogenase. | |
| DE3788352D1 (en) | METHOD FOR PRODUCING A HETEROLOGICAL PROTEIN IN INSECT CELLS. | |
| DE68910771D1 (en) | Process for the preparation of improved protein hydrolyzate. | |
| DE3584029D1 (en) | EXPRESSION VECTORS, DNA FRAGMENTS, PEPTIDES, HOST AND METHOD FOR PRODUCING PEPTIDES. | |
| ATE125298T1 (en) | METHOD FOR PRODUCING MOTILIN-LIKE POLYPEPTIDES AND ITS EXPRESSION. | |
| DE3682709D1 (en) | METHOD FOR PRODUCING L-THREONIN BY FERMENTATION. | |
| DE58905141D1 (en) | METHOD FOR PRODUCING CYCLOPROPANCARBONIC ACID AMIDE. | |
| DE3673054D1 (en) | CONTINUOUS PROCESS FOR PRODUCING ETHANOL BY BACTERIAL FERMENTATION. | |
| DE3786870D1 (en) | METHOD FOR PRODUCING PROTEINS. | |
| DE3884261D1 (en) | Process for the production of foreign proteins in Streptomycetes. | |
| DE68902379D1 (en) | METHOD FOR PRODUCING IMPROVED PROTEIN HYDROLYSATE. |